Atlas Trials

PROCLAIM: Germline Genetic Testing for Prostate Cancer Patients

Clinical trial NCT05447637 · COMPLETED

Trial details

NCT number
NCT05447637
Sponsor
Invitae Corporation
Status
COMPLETED
Study type
OBSERVATIONAL
Prostate Cancer
Start date
2019-11-01
Primary completion
2021-07-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.